Pneumoconiosis screening: Difference between revisions
No edit summary |
|||
| Line 15: | Line 15: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
Future methods of screening workers include measuring serum SMRP and fibulin-3, CEA, and urinary 8-OHdG and breath testing of pentane, C5-C7 alkanes, and methylated alkanes. <ref name="pmid32310362">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume= | issue= | pages= | pmid=32310362 | doi= | pmc= | url= }} </ref> <ref name="pmid30955520">{{cite journal| author=Perlman DM, Maier LA| title=Occupational Lung Disease. | journal=Med Clin North Am | year= 2019 | volume= 103 | issue= 3 | pages= 535-548 | pmid=30955520 | doi=10.1016/j.mcna.2018.12.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30955520 }} </ref> <ref name="pmid30946771">{{cite journal| author=Yang HY| title=Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals. | journal=PLoS One | year= 2019 | volume= 14 | issue= 4 | pages= e0214808 | pmid=30946771 | doi=10.1371/journal.pone.0214808 | pmc=6448873 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30946771 }} </ref> | |||
==References== | ==References== | ||
Revision as of 18:09, 29 April 2021
|
Pneumoconiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pneumoconiosis screening On the Web |
|
American Roentgen Ray Society Images of Pneumoconiosis screening |
|
Risk calculators and risk factors for Pneumoconiosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
Future methods of screening workers include measuring serum SMRP and fibulin-3, CEA, and urinary 8-OHdG and breath testing of pentane, C5-C7 alkanes, and methylated alkanes. [1] [2] [3]
References
- ↑ "StatPearls". 2021. PMID 32310362 Check
|pmid=value (help). - ↑ Perlman DM, Maier LA (2019). "Occupational Lung Disease". Med Clin North Am. 103 (3): 535–548. doi:10.1016/j.mcna.2018.12.012. PMID 30955520.
- ↑ Yang HY (2019). "Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals". PLoS One. 14 (4): e0214808. doi:10.1371/journal.pone.0214808. PMC 6448873. PMID 30946771.